George Katrina
School of Law, University of Western Sydney, Penrith South DC NSW 1797, Australia.
Reprod Biomed Online. 2007 Aug;15(2):127-33. doi: 10.1016/s1472-6483(10)60700-6.
As more and more countries open their doors to human cloning and embryonic stem cell research, scientists will be confronted with one fundamental problem: where will all the eggs come from? The mass harvesting of eggs raises serious issues about women's health, status and well-being. This paper critically examines proposals for ova supply such as altruistic donation, surplus IVF eggs and commercial sale. It questions the meaningfulness of informed consent and the risk-benefit ratio in a climate where powerful economic and social forces increasingly view the risks to women as the necessary trade-off for scientific advance.
